Corrected: OFFICIAL-BRIEF-Crossject reports positive results with needle free ZENEO Methotrexate

Crossject SA

25/11/2014 12:19

(Corrects spelling of Methotrexate in the story. The company 
corrected its own statement.) 
    Nov 25 (Reuters) - Crossject SA  ALCJ.PA  
    * Reports positive results from bioequivalence study with 
needle free ZENEO Methotrexate 
    * Announces similarity between ZENEO Methotrexate 
needle-free injection system and current injectable formulation 
    * Zeneo Methotrexate meets its objectives in key 
bioequivalence study 
 
Source text: http://bit.ly/1zUotrg 
Further company coverage:  ALCJ.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;)) 
 
Keywords: CROSSJECT/BRIEF